What is SHINE?
Founded in 2005 by Greg Piefer, SHINE is dedicated to improving the world through nuclear technology, employing a commercially practical, growth-based approach to explore near-term market applications of fusion. The company's mission centers on developing and deploying nuclear technology for a variety of uses, aiming to establish a sustainable and impactful presence in the energy landscape.
How much funding has SHINE raised?
SHINE has raised a total of $796.8M across 10 funding rounds:
Debt
$6.9M
Series B
$30M
Corporate Investment
$50M
Debt
$1M
Unspecified
$94.6M
Series C
$150M
Other Financing Round
$70M
Private Equity
$240M
Debt (2017): $6.9M, investors not publicly disclosed
Series B (2018): $30M, investors not publicly disclosed
Corporate Investment (2019): $50M backed by Oaktree Capital Management L.P.
Debt (2020): $1M with participation from PPP
Unspecified (2021): $94.6M, investors not publicly disclosed
Series C (2021): $150M supported by Koch Disruptive Technologies, Baillie Gifford, and Fidelity Investments
Other Financing Round (2023): $70M featuring Fidelity Investments and Baillie Gifford
Private Equity (2026): $240M backed by Deerfield, Oaktree Capital Management, Fidelity Investments (FMR, NantWorks, Pelican Energy Partners, and Sumitomo Corporation of Americas
Key Investors in SHINE
Koch Disruptive Technologies
Koch Disruptive Technologies is an investment arm focused on identifying and backing transformative technologies and innovative companies that have the potential to reshape industries. Their investment in SHINE suggests a strategic interest in advanced energy solutions.
Deerfield
Deerfield Management is an investment firm focused on advancing healthcare through investment, intelligence, and philanthropy. The firm supports companies across the healthcare ecosystem with flexible funding models and drives innovation using AI, data, and market research.
Baillie Gifford
Baillie Gifford is an investment management firm that specializes in giving investment advice. Baillie Gifford was founded in Edinburgh in 1908 and still has its headquarters in the city.
What's next for SHINE?
The substantial enterprise-level funding indicates SHINE is poised for significant expansion and further development of its fusion technology. This strategic capital infusion will likely accelerate research, scale operations, and potentially bring its innovative nuclear solutions closer to market realization. The company's trajectory suggests a focus on solidifying its position as a leader in the commercialization of fusion power.
See full SHINE company page
